The DOI matches its Crossref record.
Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions.
Abstract
A cDNA library was prepared from the murine Th cell line Th2 D.10 and used to clone the murine homologue of Ox40 by polymerase chain reaction. Comparison of the mouse sequence with the rat revealed greater than 90% homology between the two sequences at both the DNA and protein level. Northern blot analysis found that, as in the rat, Ox40 expression appears to be restricted to activated T cells. A chimeric receptor globulin was prepared to include the mouse Ox40 extracellular domain coupled to the hinge-CH2-CH3 domains of human IgG1 (Ox40-Ig). This soluble form of the molecular was then used to identify cells bearing a ligand for Ox40. FACS analysis revealed that Ox40-Ig bound to a subset of peritoneal B cells as well as to a fraction of LPS-activated splenic B cells. Immunostaining of spleen sections using an Ag-specific conjugate and Ox40-Ig found a significant proportion of antibody-forming cells co-stained with Ox40-Ig. Immunoprecipitation of cell-surface radiolabeled peritoneal B cells suggests a specific interaction with a protein of 70 kDa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Morad, G., Helmink, B. A., Sharma, P., & Wargo, J. A. (2021) · Cell · doi:10.1016/j.cell.2021.09.020 · Cited by 1,648
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
Hart, D. N. J. (1997) · Blood · doi:10.1182/blood.v90.9.3245 · Cited by 1,483
OX40 Promotes Bcl-xL and Bcl-2 Expression and Is Essential for Long-Term Survival of CD4 T Cells
Rogers, P. R., Song, J., Gramaglia, I., Killeen, N., & Croft, M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00191-1 · Cited by 646
Subspecialization of Cxcr5+ T Cells
Kim, C. H., Rott, L. S., Clark-Lewis, I., Campbell, D. J., Wu, L., & Butcher, E. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1373 · Cited by 625
The significance of OX40 and OX40L to T‐cell biology and immune disease
Croft, M., So, T., Duan, W., & Soroosh, P. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00766.x · Cited by 604
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Croft, M. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101243 · Cited by 548
Ox-40 Ligand: A Potent Costimulatory Molecule for Sustaining Primary CD4 T Cell Responses
Gramaglia, I., Weinberg, A. D., Lemon, M., & Croft, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6510 · Cited by 527
OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients
Curti, B. D., Kovacsovics-Bankowski, M., Morris, N., Walker, E., Chisholm, L., Floyd, K., Walker, J., Gonzalez, I., Meeuwsen, T., Fox, B. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4174 · Cited by 496
Pulè, M. A., Straathof, K. C., Dotti, G., Heslop, H. E., Rooney, C. M., & Brenner, M. K. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.016 · Cited by 487
OX40 costimulation turns off Foxp3+ Tregs
Vu, M. D., Xiao, X., Gao, W., Degauque, N., Chen, M., Kroemer, A., Killeen, N., Ishii, N., & Chang Li, X. (2007) · Blood · doi:10.1182/blood-2007-01-070748 · Cited by 428
Gramaglia, I., Jember, A., Pippig, S. D., Weinberg, A. D., Killeen, N., & Croft, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3043 · Cited by 409
HUMAN T CELL LEUKEMIA VIRUS TYPE I (HTLV-I) AND HUMAN DISEASES
Uchiyama, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.15 · Cited by 392
Stüber, E., Neurath, M., Calderhead, D., Perry Fell, H., & Strober, W. (1995) · Immunity · doi:10.1016/1074-7613(95)90031-4 · Cited by 390
Self-citationFlynn, S., Toellner, K.-M., Raykundalia, C., Goodall, M., & Lane, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.297 · Cited by 351
Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
Sugamura, K., Ishii, N., & Weinberg, A. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1371 · Cited by 335
Weinkove, R., George, P., Dasyam, N., & McLellan, A. D. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1049 · Cited by 324
Kopf, M., Ruedl, C., Schmitz, N., Gallimore, A., Lefrang, K., Ecabert, B., Odermatt, B., & Bachmann, M. F. (1999) · Immunity · doi:10.1016/s1074-7613(00)80144-2 · Cited by 321
Ox40-Ligand Has a Critical Costimulatory Role in Dendritic Cell:T Cell Interactions
Chen, A. I., McAdam, A. J., Buhlmann, J. E., Scott, S., Lupher, M. L., Greenfield, E. A., Baum, P. R., Fanslow, W. C., Calderhead, D. M., Freeman, G. J., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80143-0 · Cited by 321
Self-citationTiming of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40
Messenheimer, D. J., Jensen, S. M., Afentoulis, M. E., Wegmann, K. W., Feng, Z., Friedman, D. J., Gough, M. J., Urba, W. J., & Fox, B. A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2677 · Cited by 321
CD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair
Van Kooten, C., & Banchereau, J. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60865-2 · Cited by 311
Imura, A., Hori, T., Imada, K., Ishikawa, T., Tanaka, Y., Maeda, M., Imamura, S., & Uchiyama, T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2185 · Cited by 309
Tumor necrosis factor receptor superfamily members and their ligands
Armitage, R. J. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90119-8 · Cited by 299
Stüber, E., & Strober, W. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.979 · Cited by 286
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
Wang, X., Guo, G., Guan, H., Yu, Y., Lu, J., & Yu, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1085-3 · Cited by 286
Baum, P. R., Gayle, R. B., Ramsdell, F., Srinivasan, S., Sorensen, R. A., Watson, M. L., Seldin, M. F., Baker, E., Sutherland, G. R., & Clifford, K. N. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06715.x · Cited by 283
Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand
Murata, K., Ishii, N., Takano, H., Miura, S., Ndhlovu, L. C., Nose, M., Noda, T., & Sugamura, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.365 · Cited by 283
OX40, OX40L and Autoimmunity: a Comprehensive Review
Webb, G. J., Hirschfield, G. M., & Lane, P. J. L. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8498-3 · Cited by 277
Godfrey, W. R., Fagnoni, F. F., Harara, M. A., Buck, D., & Engleman, E. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.757 · Cited by 271
OX40 (CD134) Controls Memory T Helper 2 Cells that Drive Lung Inflammation
Salek-Ardakani, S., Song, J., Halteman, B. S., Jember, A. G.-H., Akiba, H., Yagita, H., & Croft, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021937 · Cited by 256
Metadata
- Authors
- Calderhead, D. M., Buhlmann, J. E., van den Eertwegh, A. J. M., Claassen, E., Noelle, R. J., & Fell, H. P.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-11
- Volume
- 151
- Issue
- 10
- Pages
- 5261-5271
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1791922236
- Cited by
- 202
- References
- 0
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.